Oncology

Machine learning artificial intelligence AI database
Biotech

Rakovina deepens AI focus with collab to select cancer targets

The financial details were left vague, but we do know that Rakovina will pay a “low upfront fee” to begin work on each selected target.
James Waldron Sep 17, 2024 9:20am
IPO initial public offering Wall Street

Kairos goes public with $6M IPO to fund trials of cancer drug

Sep 17, 2024 5:08am
digital money budget dollar sign

European oncology org extends partnership with Medidata

Sep 11, 2024 3:55pm
illustration of two people putting puzzle pieces together merger and acquisition concept

Genentech's cancer restructure made 'for scientific reasons'

Sep 10, 2024 5:56am
Graphic of two hands shaking under a red and purple light

Bayer pens $547M pact to push boundaries of noncoding RNA

Aug 28, 2024 9:00am
IPO initial public offering markets raise financing

Bicara, Zenas seek IPOs to push late-phase assets toward market

Aug 23, 2024 5:07am
More News

Founder-led biotech raises $11M for preclinical cancer portfolio

Aug 20, 2024 11:05am

Oncology CRO taps biotech leader as new CMO

Aug 13, 2024 2:05pm

Halda's $126M will advance 'hold and kill' tumor drugs

Aug 12, 2024 7:00am

Eisai plants molecular glue SEED with $1.5B biobucks deal

Aug 6, 2024 10:24am